I agree. These prolonged periods of silence only serve to increase anxiety and doubt. Good management teams keep shareholders informed along the journey, even if it is just a brief update on progress/current status. Management should not assume that shareholders know the reason for the delay in assay results.
Ann: Investor Presentation, page-49
Add USL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
-0.010(4.55%) |
Mkt cap ! $75.48M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.5¢ | 21.0¢ | $17.44K | 83.06K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 62048 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 40905 | 2 |
View Market Depth
| Last trade - 11.48am 02/10/2024 (20 minute delay) ? |
| USL (ASX) Chart |